NYSE: ODC

Oil-Dri Corp of America

CIK 0000074046 · SIC 3990 · Miscellaneous Manufacturing

Small Revenue $486M Assets $409M as of Aug 30, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (P 10-Q) is open in full — no account needed.

8-K Filed Jun 8, 2026 · Period ending Jun 8, 2026

Oil-Dri reports Q3 FY2026 earnings, declares $0.225 dividend, authorizes 500K share buyback

3 material changes detected. Sign up free to read the summary.

10-Q Filed Jun 8, 2026 · Period ending Apr 30, 2026

revenue $126.3M, net income $14.5M. Oil-Dri sales growth slows to 24.8% as margin compression and cost inflation offset volume gains

5 material changes detected. Sign up free to read the summary.

Partner

Trade ODC commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Apr 3, 2026 · Period ending Apr 3, 2026

Oil-Dri files routine updates to executive compensation plan and equity award forms

2 material changes detected. Sign up free to read the summary.

8-K Filed Mar 12, 2026 · Period ending Mar 12, 2026

Oil-Dri declares quarterly dividend of $0.205/share Common, $0.153/share Class B

1 material change detected. Sign up free to read the summary.

10-Q Filed Mar 11, 2026 · Period ending Jan 31, 2026

Summary not yet generated.

8-K Filed Mar 11, 2026 · Period ending Mar 11, 2026

Summary not yet generated.

10-K Filed Oct 9, 2025 · Period ending Jul 31, 2025

Summary not yet generated.

10-Q Filed Jun 5, 2025 · Period ending Apr 30, 2025

Summary not yet generated.

10-K Filed Oct 10, 2024 · Period ending Jul 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Jun 8, 2026 (period ending Apr 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations (Unaudited)

(in thousands, except for share and per share amounts, unaudited)

Description Nine months ended April 30, 2026 Nine months ended April 30, 2025
Net Sales 364,552 360,360
Cost of Goods Sold (263,027) (252,110)
Gross Profit 101,525 108,250
Selling, General and Administrative Expenses (51,785) (55,674)
Income from Operations 49,740 52,576
Other Income (Expense)
Interest expense (1,648) (1,888)
Interest income 1,087 358
Other, net 2,220 (336)
Total Other Income (Expense), Net 1,659 (1,866)
Income Before Income Taxes 51,399 50,710
Income Tax Expense (8,848) (9,769)
Net Income 42,551 40,941
Earnings Per Share
Basic Common 3.15 3.03
Basic Class B 2.37 2.28
Diluted Common 2.93 2.81
Diluted Class B 2.37 2.28
Average Shares Outstanding
Basic Common 9,884 9,882
Basic Class B 4,035 3,991
Diluted Common 13,919 13,873
Diluted Class B 4,035 3,991
Dividends Declared Per Share
Common Stock 0.590 0.465
Class B Stock 0.441 0.350

Condensed Consolidated Balance Sheet (Unaudited)

(in thousands, except for share and per share amounts, unaudited)

Description April 30, 2026 July 31, 2025
Current Assets
Cash and cash equivalents 62,941 50,458
Accounts receivable, net of allowances of $1,065 and $1,493 at April 30, 2026 and July 31, 2025, respectively 75,772 69,370
Inventories, net 52,420 51,594
Prepaid expenses and other assets 5,212 5,961
Total Current Assets 196,345 177,383
Other Assets
Property, plant and equipment, net 150,799 149,704
Goodwill 16,017 16,017
Trademarks, trade names and patents, net of accumulated amortization of $724 and $693 at April 30, 2026 and July 31, 2025, respectively 6,575 6,603
Customer list, net of accumulated amortization of $10,124 and $9,278 at April 30, 2026 and July 31, 2025, respectively 18,061 18,907
Deferred income taxes 1,182 1,291
Operating lease right-of-use assets 13,440 14,219
Other 6,371 7,553
Total Other Assets 212,445 214,294
Total Assets 408,790 391,677
LIABILITIES & STOCKHOLDERS’ EQUITY
Current Liabilities
Current maturities of notes payable 1,000 1,000
Accounts payable 13,848 16,808
Dividends payable 2,750 2,444
Operating lease liabilities 3,936 4,071
Accrued expenses 38,386 44,864
Total Current Liabilities 59,920 69,187
Noncurrent Liabilities
Long-term debt, net of unamortized debt issuance costs of $153 and $183 at April 30, 2026 and July 31, 2025, respectively 38,847 38,817
Deferred compensation 6,419 5,777
Long-term operating lease liabilities 10,546 11,296
Other 7,832 7,540
Total Noncurrent Liabilities 63,644 63,430
Total Liabilities 123,564 132,617
Commitments and contingencies (See note 7)
Stockholders’ Equity
Common Stock, par value $.10 per share, issued 15,349,661 shares at April 30, 2026 and 15,276,261 shares at July 31, 2025 1,535 1,528
Class B Stock, par value $.10 per share, issued 4,650,484 shares at April 30, 2026 and 4,650,484 shares at July 31, 2025 465 465
Additional paid-in capital 70,344 66,138
Retained earnings 312,119 277,500
Accumulated other comprehensive income 976 969
Less Treasury Stock, at cost (5,095,266 Common and 416,544 Class B shares at April 30, 2026 and 4,902,881 Common and 380,628 Class B shares at July 31, 2025) (100,213) (87,540)
Total Stockholders’ Equity 285,226 259,060
Total Liabilities & Stockholders’ Equity 408,790 391,677

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands, unaudited)

Description Nine months ended April 30, 2026 Nine months ended April 30, 2025
Net Income 42,551 40,941
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 17,186 16,391
Non-cash stock-based compensation 4,077 3,880
Provision for bad debts and cash discounts (169) 436
Loss on impairment of patent applications 48
Accretion of asset retirement obligation 190 143
Loss on the disposals of property, plant and equipment 413 29
(Increase) decrease in assets:
Accounts receivable (6,203) (3,816)
Inventories (766) (2,547)
Prepaid expenses 463 1,234
Deferred income taxes 73 (116)
Other assets 4,091 3,012
Increase (decrease) in liabilities:
Accounts payable (641) 495
Accrued expenses (5,529) (2,268)
Deferred compensation 642 548
Other liabilities (3,170) (3,422)
Total Adjustments 10,657 14,047
Net Cash Provided by Operating Activities 53,208 54,988
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures (20,918) (24,483)
Proceeds from sale of property, plant and equipment 89
Acquisition of a business (115)
Dispositions of short-term investments 312
Net Cash Used in Investing Activities (20,606) (24,509)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments on revolving credit facility (10,000)
Dividends paid (7,626) (6,290)
Purchases of treasury stock (12,537) (2,233)
Net Cash Used in Financing Activities (20,163) (18,523)
Effect of exchange rate changes on cash and cash equivalents 44 38
Net Increase in Cash and Cash Equivalents 12,483 11,994
Cash, Cash Equivalents and Restricted Cash, Beginning of Period 50,458 24,481
Cash, Cash Equivalents and Restricted Cash, End of Period 62,941 36,475

Amounts as printed on the EDGAR/iXBRL face — (in thousands, except for share and per share amounts, unaudited); (in thousands, unaudited). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing